These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7083508)

  • 1. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K; Singh BN; Hendrickson JA; Reed AW; Melmed S; Hershman J
    Circulation; 1982 Jul; 66(1):202-11. PubMed ID: 7083508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
    Kerin NZ; Blevins RD; Benaderet D; Faitel K; Jarandilla R; Garfinkel C; Klein S; Rubenfire M
    Am J Cardiol; 1986 Jan; 57(1):128-30. PubMed ID: 3942055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy.
    Singh BN; Nademanee K
    Am Heart J; 1983 Oct; 106(4 Pt 2):857-69. PubMed ID: 6412534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effects of amiodarone in patients with refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Cappello G
    Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of serum amiodarone levels with abnormalities in the metabolism of thyroxine.
    Anastasiou-Nana M; Koutras DA; Levis G; Souvatzoglou A; Boukis MA; Moulopoulos SD
    J Endocrinol Invest; 1984 Aug; 7(4):405-7. PubMed ID: 6501809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum reverse T3 and amiodarone efficacy.
    Haberman RJ; Ladenson PW; Griffith LS; Veltri EP
    Clin Cardiol; 1989 Mar; 12(3):140-4. PubMed ID: 2466595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.
    Melmed S; Nademanee K; Reed AW; Hendrickson JA; Singh BN; Hershman JM
    J Clin Endocrinol Metab; 1981 Nov; 53(5):997-1001. PubMed ID: 7287882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes.
    Polikar R; Goy JJ; Schlapfer J; Lemarchand-Beraud T; Biollaz J; Magnenat P; Nicod P
    Am J Cardiol; 1986 Nov; 58(10):987-91. PubMed ID: 2430444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines.
    Kannan R; Ookhtens M; Chopra IJ; Singh BN
    Endocrinology; 1984 Nov; 115(5):1710-6. PubMed ID: 6489259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
    Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
    Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.
    Burger A; Dinichert D; Nicod P; Jenny M; Lemarchand-Béraud T; Vallotton MB
    J Clin Invest; 1976 Aug; 58(2):255-9. PubMed ID: 783194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute antiarrhythmia treatment with amiodarone and blood levels of thyroid hormones].
    Gheri RG; Marchi F; Zambaldi G; Multinu D; Paladini S; Fazzini PF
    G Ital Cardiol; 1987 Apr; 17(4):340-3. PubMed ID: 2443414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of the reverse T3 (rT3) determination in patients under chronic treatment with amiodarone].
    de los Angeles Valenzuela M; Bianchi C; Meruane J; Pineda G
    Rev Med Chil; 1984 Mar; 112(3):228-32. PubMed ID: 6473963
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of effect of 3,3'5'-triiodothyronine (reverse T3) on cardiac function in the rabbit.
    Kannan R; Kato R; Takikawa R; Huang TS; Chopra IJ; Singh BN
    Endocr Res; 1988-1989; 14(4):227-42. PubMed ID: 3250865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone and thyroid hormone action.
    Franklyn JA; Davis JR; Gammage MD; Littler WA; Ramsden DB; Sheppard MC
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):257-64. PubMed ID: 3978832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing.
    Singh BN; Nademanee K; Kannan R; Ikeda N
    Pacing Clin Electrophysiol; 1984 Jan; 7(1):109-24. PubMed ID: 6199755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of amiodarone in children.
    Coumel P; Lucet V; Do Ngoc D
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):930-9. PubMed ID: 6195613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.
    Hershman JM; Nademanee K; Sugawara M; Pekary AE; Ross R; Singh BN; DiStefano JJ
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):193-9. PubMed ID: 3953231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone and thyroid status in refractory arrhythmias.
    Piffanelli A; Pelizzola D; Ricci L; Codecà L; Giovannini G; Giganti M; Colamussi V
    Jpn Heart J; 1988 Jan; 29(1):45-55. PubMed ID: 3398243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.